SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 22.38
-0.88 (-3.76%)
Mar 26, 2025, 10:33 AM GMT+1
SkinBioTherapeutics Revenue
In the fiscal year ending June 30, 2024, SkinBioTherapeutics had annual revenue of 1.21M GBP with 815.26% growth. SkinBioTherapeutics had revenue of 1.10M in the half year ending June 30, 2024, with 1,986.82% growth.
Revenue
1.21M
Revenue Growth
+815.26%
P/S Ratio
18.20
Revenue / Employee
178.57K
Employees
15
Market Cap
53.11M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |